Enter assignee name

Forward Citations = 30

Loading Chart...

7 inventors (with patents filed for the assignee):

Jacob Glanville (8 out of 18 patents)

Shahrad Daraeikia (6 out of 6 patents)

I-Chieh Wang (6 out of 6 patents)

4. Jean-Philippe Bürckert (5 out of 5 patents)

5. Sawsan Youssef (5 out of 8 patents)

6. Sindy Andrea Liao-Chan (3 out of 3 patents)

7. Sindy Andrea Liao Chan (3 out of 3 patents)

8 patents: Sort by Forward Citations

1. 12043647 - Epitope focusing by variable effective antigen surface concentration (2024-07-23),

2. 11560409 - Epitope focusing by variable effective antigen surface concentration (2023-01-24),

3. 11053304 - Anti-SARS-Cov-2 antibodies derived from 6nb6 (2021-07-06),

4. 11034762 - Anti-SARS-Cov-2 antibodies derived from CR3022 (2021-06-15),

5. 11028167 - Anti-SARS-Cov-2 antibodies derived from 3bgf (2021-06-08),

6. 11028150 - Anti-SARS-CoV-2 antibodies derived from 2DD8 (2021-06-08),

7. 11021532 - Superhuman anti-SARS-CoV-2 antibodies and uses thereof (2021-06-01),

8. 11021531 - Anti-SARS-Cov-2 antibodies derived from 2GHW (2021-06-01),

Centivax, Inc. is a biotechnology company focused on developing innovative vaccines and therapeutics for infectious diseases. With a strong emphasis on research and development, Centivax is committed to addressing global health challenges and improving the quality of life for people around the world. Visit our website to learn more about our cutting-edge solutions and scientific advancements.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

8 Patents

#116 in South San Francisco, CA

#8,278 in California

#34,852 in US

South San Francisco, CA, United States of America

Centivax, Inc.